Prostate Cancer Progression Model with Fibroblasts
Author Information
Author(s): Ishii Kenichiro, Iguchi Kazuhiro, Matsuda Chise, Hirokawa Yoshifumi, Sugimura Yoshiki, Watanabe Masatoshi
Primary Institution: Mie University Graduate School of Medicine
Hypothesis
To prevent the development and progression of castration-resistant prostate cancer (CRPC), preservation of androgen receptor (AR) signaling after androgen deprivation therapy (ADT) is essential.
Conclusion
The study provides insights into how different LNCaP sublines interact with fibroblasts, affecting their androgen sensitivity and response to ADT.
Supporting Evidence
- Prostate cancer cells can lose androgen sensitivity and AR dependency over time.
- Different LNCaP sublines exhibit varying responses to ADT based on their interaction with fibroblasts.
- Fibroblasts secrete factors that can activate AR signaling in prostate cancer cells even in the absence of androgens.
Takeaway
This research shows how prostate cancer cells change over time and how they interact with surrounding cells, which can help in finding better treatments.
Methodology
The study involved creating and characterizing LNCaP sublines with varying androgen sensitivity and AR dependency, and examining their interactions with fibroblasts in vitro and in vivo.
Limitations
The study primarily focuses on specific LNCaP sublines and may not fully represent all prostate cancer types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website